Received Mar 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 34mf9 | — |
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
received 1st dose of Kinrix vaccine at the age of 7 years; another nurse accidentally administered KINRIX today to a patient instead of boostrix; Inappropriate age at vaccine administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old male patient who received DTPa-IPV (Kinrix) (batch number 34mf9, expiry date 13-FEB-2026) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis and DTPa-IPV (Kinrix) for prophylaxis. On 28-FEB-2025, the patient received the 2nd dose of Kinrix. On an unknown date, the patient received Boostrix and the 1st dose of Kinrix. On 28-FEB-2025, an unknown time after receiving Kinrix and not applicable after receiving Boostrix and Kinrix, the patient experienced wrong vaccine administered (Verbatim: another nurse accidentally administered KINRIX today to a patient instead of boostrix) and inappropriate age at vaccine administration (Verbatim: Inappropriate age at vaccine administration). On an unknown date, the patient experienced inappropriate age at vaccine administration (Verbatim: received 1st dose of Kinrix vaccine at the age of 7 years). The outcome of the wrong vaccine administered, inappropriate age at vaccine administration and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:2 8-FEB-2025 Reporter was the Health Care Professional who stated that another nurse accidentally administered KINRIX today to a patient instead of Boostrix which led to wrong vaccine administered and Inappropriate age at vaccine administration. The patient received their first dose of KINRIX when they were 7 years old which led to inappropriate age at vaccine administration This case was one of the three case reported by the same reporter for different patient.; Sender's Comments: US-GSK-US2025025495:same reporter US-GSK-US2025025491:same reporter US-GSK-US2023044436:same reporter